Connect your AI

ADMA Biologics ADMA ADMA Bio Manufacturing — Gain On Sale Of Investments

Other segment segments

Plasma Collection Centers

$7.98M—

Similar metrics at other companies

GBXManufacturing — Gain Loss On Sale Of Other Assets

$200K0.0%

SEPNGain On Sale Of Non Financial Asset

$3.13M—

CEEngineered Materials — Gain (loss) on disposition of business and assets, net

$48M+1,100%

NKTRGain On Sale Of The Huntsville Manufacturing Facility

$0-100%

CRHAmericas Materials Solutions — Gain on divestitures and investments

$4.75M—

APOAsset Management — Gain (Loss) on Investments

-$112M-153%

Other financials

Income statement

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

Market cap$2.02B-54.5%

Profitability

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:GainOnSaleOfInvestments.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's adma bio manufacturing — gain on sale of investments.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ADMA Biologics's ADMA bio manufacturing — gain on sale of investments?: ADMA Biologics (ADMA) reported ADMA bio manufacturing — gain on sale of investments of $0 in Q1 2026.
What does ADMA bio manufacturing — gain on sale of investments mean?: Represents the realized profit from the disposal of financial assets or equity holdings held by the manufacturing segment. It serves as a non-operating item that can impact net income but does not reflect core operational performance.